Autologous cultured myoblasts and fibroblasts - Innovacell BiotechnologieAlternative Names: Urocell
Latest Information Update: 07 Jul 2008
At a glance
- Originator Innovacell Biotechnologie GmbH
- Class Cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Stress incontinence
Most Recent Events
- 31 Dec 2006 Launched for Stress incontinence in Switzerland (Intravesicular)
- 31 Dec 2006 Launched for Stress incontinence in Germany (Intravesicular)
- 31 Dec 2006 Launched for Stress incontinence in Belgium (Intravesicular)